Informed consent voluntary
Item
voluntary consent form
boolean
C0021430 (UMLS CUI [1,1])
C0439656 (UMLS CUI [1,2])
Age | Mucosis fungoides | Primary cutaneous anaplastic large cell lymphoma
Item
male or female patients 18 years or older with diagnosis of mf or pcalcl
boolean
C0001779 (UMLS CUI [1,1])
C0026948 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2,1])
C1301362 (UMLS CUI [2,2])
Patients with pcalcl who have received prior radiation therapy or at least 1 prior systemic therapy | Patients with mf who have received at least 1 prior systemic therapy
Item
patients with pcalcl who have received prior radiation therapy or at least 1 prior systemic therapy; patients with mf who have received at least 1 prior systemic therapy
boolean
C1301362 (UMLS CUI [1,1])
C0279134 (UMLS CUI [1,2])
C1301362 (UMLS CUI [2,1])
C1515119 (UMLS CUI [2,2])
C0332152 (UMLS CUI [2,3])
C0026948 (UMLS CUI [3,1])
C1515119 (UMLS CUI [3,2])
C0332152 (UMLS CUI [3,3])
CD30+ disease histologically confirmed
Item
histologically confirmed cd30+ disease by central laboratory assessment and pathology review
boolean
C3888910 (UMLS CUI [1,1])
C0750484 (UMLS CUI [1,2])
C0030664 (UMLS CUI [1,3])
Eastern cooperative oncology group (ecog) performance status
Item
eastern cooperative oncology group (ecog) performance status ≤ 2
boolean
C1520224 (UMLS CUI [1])
Postmenopausal state | Surgically sterile | Willing to practise 2 effective contraceptive methods | Willing to practise sexual abstinence
Item
female patients who are post menopausal, surgically sterile, or agree to practice 2 effective methods of contraception or agree to practice true abstinence, when this is in line with the preferred and usual lifestyle of the subject
boolean
C0232970 (UMLS CUI [1])
C0015787 (UMLS CUI [2])
C0700589 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0600109 (UMLS CUI [3,3])
C0036899 (UMLS CUI [4,1])
C0600109 (UMLS CUI [4,2])
Male patients willing to practice effective barrier contraception | Willing to practice true sexual abstinence
Item
male patients who agree to practice effective barrier contraception or agree to practice true abstinence, when this is in line with the preferred and usual lifestyle of the subject
boolean
C0004764 (UMLS CUI [1,1])
C0086582 (UMLS CUI [1,2])
C0600109 (UMLS CUI [1,3])
C0036899 (UMLS CUI [2,1])
C0086582 (UMLS CUI [2,2])
C0600109 (UMLS CUI [2,3])
Clinical laboratory values as specified in protocol
Item
clinical laboratory values as specified in protocol
boolean
C1254595 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
C0243161 (UMLS CUI [1,3])
C2348563 (UMLS CUI [1,4])
Concurrent diagnosis of systemic aclc | Other non-hodgkin lymphoma | Sezary syndrome | B2 disease
Item
a concurrent diagnosis of systemic alcl,other non hodgkin lymphoma(excluding lyp) or sezary syndrome or b2 disease
boolean
C0205420 (UMLS CUI [1,1])
C1336548 (UMLS CUI [1,2])
C0205420 (UMLS CUI [2,1])
C0024305 (UMLS CUI [2,2])
C0205420 (UMLS CUI [3,1])
C0036920 (UMLS CUI [3,2])
C0205420 (UMLS CUI [4,1])
C0523880 (UMLS CUI [4,2])
Cardiovascular conditions specified in study protocols
Item
patients with cardiovascular conditions specified in protocols
boolean
C0007222 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
History of another primary malignancy not in remission for at least 3 years
Item
patients with history of another primary malignancy not in remission for at least 3 years
boolean
C0262926 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C0544452 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Known active cerebral/meningeal disease | HIV infection | Hepatitis B | Hepatitis C infection
Item
known active cerebral/meningeal disease, hiv infection, hepatitis b or hepatitis c infection
boolean
C0019693 (UMLS CUI [1,1])
C0205177 (UMLS CUI [1,2])
C0019163 (UMLS CUI [2,1])
C0205177 (UMLS CUI [2,2])
C0019196 (UMLS CUI [3,1])
C0205177 (UMLS CUI [3,2])
C0234387 (UMLS CUI [4,1])
C0205177 (UMLS CUI [4,2])
C0154728 (UMLS CUI [5,1])
C0205177 (UMLS CUI [5,2])
Recent oral retinoid therapy
Item
oral retinoid therapy for any indication within 3 weeks of study entry
boolean
C0442027 (UMLS CUI [1,1])
C0035339 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0332185 (UMLS CUI [1,4])
Corticosteroid therapy recent | Immunosuppresive chemotherapy recent | Antibody-directed immune therapy | Ammunoglobulin-based immune therapy
Item
corticosteroid therapy within 3 weeks or immunosuppressive chemotherapy or any antibody-directed or immunoglobulin-based immune therapy (eg, immunoglobulin replacement, other monoclonal antibody therapies) within 12 weeks of first dose of study drug
boolean
C0149783 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C3665472 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
C0003250 (UMLS CUI [3,1])
C0021083 (UMLS CUI [3,2])
C0332185 (UMLS CUI [3,3])
C0021027 (UMLS CUI [4,1])
C1705938 (UMLS CUI [4,2])
C0021083 (UMLS CUI [4,3])
C0332185 (UMLS CUI [4,4])
Lactation and brestfeeding | Positive serum pregnancy test | Positive urine pregnancy test
Item
female patients who are lactating and breastfeeding or have a positive serum pregnancy test during the screening period or a positive urine pregnancy test on day 1 of any cycle
boolean
C0022925 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0430064 (UMLS CUI [2,1])
C1446409 (UMLS CUI [2,2])
C0430056 (UMLS CUI [3,1])
C1446409 (UMLS CUI [3,2])
Previous therapy with brentuximab vedotin
Item
previous receipt of brentuximab vedotin
boolean
C2973446 (UMLS CUI [1,1])
C2114510 (UMLS CUI [1,2])